{
  "Variants Include": [
    {
      "Gene": "SLC22A1",
      "variants": [
        {
          "HGVS": "NM_047699.5:c.138P>Y (p.Y48C)",
          "cDNA Change": {
            "transcript": "NM_047699.5",
            "ref": "G",
            "alt": "Y",
            "position": "138"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "C",
            "position": "48"
          },
          "Description in input context": "c.138P>Y (p.Y48C)"
        },
        {
          "Gene": "SLC22A1",
          "variants": [
            {
              "HGVS": "NM_047699.5:c.139T>G (p.Y49C)",
              "cDNA Change": {
                "transcript": "NM_047699.5",
                "ref": "G",
                "alt": "C",
                "position": "139"
              },
              "Protein Change": {
                "ref": "G",
                "alt": "C",
                "position": "49"
              },
              "Description in input context": "c.139T>G (p.Y49C)"
            }
          ]
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0006729"
  },
  "Experiment Method": [
    {
      "Assay Method": "Co-incubation with brain cytosol",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "HEK293 cells",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Qualitative and quantitative",
      "Readout description": [
        {
          "Variant": "NM_047699.5:c.138P>Y (p.Y48C)",
          "Conclusion": "Significant increase in membrane binding",
          "Molecular Effect": "Impaired protein function",
          "Result Description": "Co-incubation with brain cytosol significantly increased membrane binding of A53T α-syn."
        },
        {
          "Variant": "NM_047699.5:c.139T>G (p.Y49C)",
          "Conclusion": "Significant increase in membrane binding",
          "Molecular Effect": "Impaired protein function",
          "Result Description": "Co-incubation with brain cytosol significantly increased membrane binding of A30P α-syn."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed to confirm consistent results."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Repetitions with technical replicates were used to assess reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-syn was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No α-syn binding control was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Not mentioned in the literature",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc testing",
        "Source": "Literature"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Membrane binding was considered normal when expressed at least 50% of untreated control",
        "Source": "Determined from literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Membrane binding less than 20% of untreated control",
        "Source": "Determining based on typical PD criteria"
      },
      "Approved assay": {
        "Approved assay": "Yes, co-incubation methods are approved for studying neurodegenerative diseases"
      }
    }
  ]
}